Table 2.
Number of women | Intention to screen response rate per 100 (%) with 95% CI | Mean age (95% CI) of responders | Intetion to screen histology outcome | ||||||
---|---|---|---|---|---|---|---|---|---|
HSIL/CIN2+ | HSIL/CIN3+ | ||||||||
no. | per 1000 (‰) with 95% CI | no. | per 1000 (‰) with 95% CI | ||||||
ALL WOMEN | All women | 26,556 | 33.8% (33.2%.34.4%) | 49.0 (48.7-49.2) | 94 | 3.5‰ (2.9‰–4.4‰) | 71 | 2.7‰ (2.1‰–3.4‰) | |
Responders | 8,972 | ||||||||
STUDY GROUPS | I1 opt-in | all | 14,400 | 34.0% (33.2%–34.8%) | 49.0 (48.7-49.3) | 49 | 3.4‰ (2.5‰–4.5‰) | 36 | 2.5‰ (1.8‰–3.5‰) |
responders | 4,896 | ||||||||
I2 opt-out | all | 9,556 | 37.7% (36.7%–38.6%) | 49.0 (48.6-49.3) | 37 | 3.9‰ (2.8‰–5.4‰) | 30 | 3.1‰ (2.2‰–4.5‰) | |
responders | 3,598 | ||||||||
P control | all | 2,600 | 18.4% (16.9%–19.9%) | 48.0 (47.2-48.9) | 8 | 3.1‰ (1.4‰–6.3‰) | 5 | 1.9‰ (0.7‰–4.8‰)) | |
responders | 478 | ||||||||
p-value | < 0.000∗ | 0.766 | 0.557 | ||||||
REGION | Celje | all | 11,055 | 33.2% (32.3%–34.0%) | 48.3 (47.9-48.6) | 38 | 3.4‰ (2.5‰–4.8‰) | 28 | 2.5‰ (1.7‰–3.7‰) |
responders | 3,666 | ||||||||
Maribor | all | 15,501 | 34.2% (33.5%–35.0%) | 49.4 (49.2-49.7) | 56 | 3.6‰ (2.8‰–4.7‰) | 43 | 2.8‰ (2.0‰–3.8‰) | |
responders | 5,306 | ||||||||
p-value | 0.070 | 0.813 | 0.708 | ||||||
LEVEL OF PROTECTION | Medium | all | 12,464 | 51.1% (50.2%–52.0%) | 48.4 (48.2-48.7) | 48 | 3.9‰ (2.9‰–5.1‰) | 33 | 2.6‰ (1.9‰–3.8‰) |
responders | 6,367 | ||||||||
No/low | all | 14,092 | 18.5% (17.8%–19.1%) | 51.1 (50.9-51.3) | 46 | 3.3‰ (2.4‰–4.4‰) | 38 | 2.7‰ (1.9‰–3.7‰) | |
responders | 2,605 | ||||||||
p-value | < 0.000∗ | 0.422 | 0.838 |
Statistically significant result at α = 0.05.